back to webinars

PPH16: Miriam Moscovitch-lopatin, Massgeneral Institute For Neurodegenerative Disease

date

26 September 2016

time & location

2:00PM, Virtual

Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington’s disease at the inaugural Powering Precision Health Summit 2016.

PPH2016 Miriam Moscovitch-Lopatin.mp4